Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7976
PUT
Atlanta Braves Holdings Series A
BATRA
$3.62B
| $1.07M | ﹤0.01% |
19,000
+3,100
| +19% | +$165K |
|
7977
Legacy Housing
LEGH
$641M
| $1.07M | ﹤0.01% |
40,685
+967
| +2% | +$22.1K |
|
7978
Coca-Cola Femsa
KOF
$23.6B
| $1.07M | ﹤0.01% |
10,052
-36,949
| -79% | -$3.87M |
|
|
XMAX
7979
XMAX Inc
XMAX
$568M
| $1.07M | ﹤0.01% |
+117,424
| New | +$943K |
|
7980
Virtus Real Asset Income ETF
VRAI
$18.6M
| $1.07M | ﹤0.01% |
38,603
+6,635
| +21% | +$184K |
|
7981
CALL
Mirum Pharmaceuticals
MIRM
$6.11B
| $1.07M | ﹤0.01% |
9,100
-2,400
| -21% | -$241K |
|
7982
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$770M
| $1.07M | ﹤0.01% |
48,992
-19,222
| -28% | -$419K |
|
7983
PUT
Atkore
ATKR
$3.19B
| $1.06M | ﹤0.01% |
14,000
-3,300
| -19% | -$249K |
|
7984
PUT
Rayonier Advanced Materials
RYAM
$561M
| $1.06M | ﹤0.01% |
135,300
-130,300
| -49% | -$1.18M |
|
7985
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.19B
| $1.06M | ﹤0.01% |
+19,466
| New | +$1.02M |
|
|
TSMX
7986
Direxion Daily TSM Bull 2X ETF
TSMX
$534M
| $1.06M | ﹤0.01% |
10,146
-11,826
| -54% | -$943K |
|
7987
CALL
Astrana Health
ASTH
$1.9B
| $1.06M | ﹤0.01% |
22,900
-60,100
| -72% | -$2.16M |
|
7988
Invesco S&P 500 Top 50 ETF
XLG
$11.4B
| $1.06M | ﹤0.01% |
17,357
-36,418
| -68% | -$2.22M |
|
|
DLLL
7989
GraniteShares 2x Long DELL Daily ETF
DLLL
$199M
| $1.06M | ﹤0.01% |
42,543
-62,801
| -60% | -$838K |
|
|
APGE
7990
PUT
DELISTED
Apogee Therapeutics
APGE
| $1.06M | ﹤0.01% |
8,000
-12,000
| -60% | -$1.08M |
|
|
AVGG
7991
PUT
Leverage Shares 2X Long AVGO Daily ETF
AVGG
$44.8M
| $1.06M | ﹤0.01% |
+38,800
| New | +$1.27M |
|
7992
Schwab US TIPS ETF
SCHP
$16B
| $1.06M | ﹤0.01% |
40,003
-41,458
| -51% | -$1.11M |
|
7993
CALL
Houlihan Lokey
HLI
$9.53B
| $1.06M | ﹤0.01% |
7,900
-1,900
| -19% | -$280K |
|
7994
PUT
Better Home & Finance Holding
BETR
$238M
| $1.06M | ﹤0.01% |
38,500
+11,600
| +43% | +$375K |
|
7995
Nabors Industries
NBR
$1.36B
| $1.06M | ﹤0.01% |
12,602
-97,219
| -89% | -$9.05M |
|
7996
National CineMedia
NCMI
$226M
| $1.06M | ﹤0.01% |
278,577
+153,970
| +124% | +$524K |
|
7997
PUT
Verra Mobility
VRRM
$538M
| $1.06M | ﹤0.01% |
249,000
+209,900
| +537% | +$2.22M |
|
|
WULX
7998
Tradr 2X Long WULF Daily ETF
WULX
$13.7M
| $1.06M | ﹤0.01% |
22,913
+5,257
| +30% | +$233K |
|
7999
Andersons Inc
ANDE
$2.43B
| $1.06M | ﹤0.01% |
15,464
-78,169
| -83% | -$5.68M |
|
8000
CALL
ADMA Biologics
ADMA
$1.96B
| $1.06M | ﹤0.01% |
126,300
-190,200
| -60% | -$1.73M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.